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Background
Some monogenic interferonopathies are caused by
innate immune dysregulation and form a subclass of
autoinflammatory disorders characterized by systemic
inflammation due to chronic Type I interferon stimula-
tion. STING-Associated Vasculopathy with Onset in
Infancy (SAVI) is an IFN-mediated disease caused by
gain-of-function mutations in TMEM173, the gene
encoding the stimulator of interferon genes (STING).
Objectives
This study was undertaken to understand the variable
disease severity of the interstitial lung disease (ILD) in
SAVI patients. We hypothesized that the severity of the
interstitial lung disease may be modulated by a common
SNP (R232H, rs1131769) that is functionally associated
with decreased IFNB1 transcription.
Methods
We studied nine SAVI patients with N154S, V155M, or
V147L mutations. Lung involvement was assessed by
chest computed tomography (CT) and pulmonary func-
tion tests (PFTs) for all patients, a lung biopsy was avail-
able for five patients. Peripheral blood genomic DNA
samples were obtained and TMEM173 (NM_198282.3)
was sequenced by Sanger technique. STING function
was evaluated in the different TMEM173 haplotypes by
IFNB1 Luciferase Reporter assays performed with cells
transfected with wildtype or mutant TMEM173 on the
R232 and the H232 backgrounds.
Results
We described the clinical features of ILD in nine SAVI
patients. Six patients had evidence of severe ILD charac-
terized by moderate to severe abnormalities on chest
CT, PFTs and/or lung biopsy. Two patients presented
with mild ILD and one did not have any evidence of
ILD. Four out of the six patients with severe ILD suc-
cumbed to pulmonary complications. Five patients with
severe ILD were homozygous for R232 (R232/R232) and
one was heterozygous for the SNP. Conversely, the two
patients with mild ILD were heterozygous (R232/H232)
and the patient without ILD was homozygous for the
H232 allele (H232/H232). Thus, the severity of intersti-
tial lung disease seems to correlate with the STING
haplotype. Transfection of HEK293T cells with the
H232 TMEM173 haplotype with or without SAVI caus-
ing mutations results in decreased IFNB1 expression in
the presence of both low affinity and high affinity
STING stimulator cGAMP in comparison with cells
transfected with the R232 haplotype. These findings sug-
gest that the H232 haplotype background may be pro-
tective from the development of ILD.
Conclusion
The variable presentation and severity of ILD in SAVI
patients seems to correlate with the TMEM173 haplo-
type at position 232 and possibly with the local induc-
tion of an IFN response. Our data suggest that common
variants can modify disease expression specific to one
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organ and provide a model to assess the variable disease
phenotype in other interferonopathies.
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